| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections# K* P' Q9 l, {1 t
Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes2 ^6 g7 s( W( ^
Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease. P$ f9 X1 D1 n8 l6 E( i3 z
Press Release |
| 20. f8 p! V6 ^' h8 w8 \; {
4 x* v8 g0 U! U6 c, K; E8 ?/ y7 e+ p | | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers
$ l" l' g+ l9 Z8 y0 p' G- r- h Press Release |
| 19. | Kerydin
, i0 F. D& J b X$ K6 k
: j& u9 M* P- `. o. ^+ L5 V | tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails
4 y* X6 ~6 U2 Q (No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL)
) |4 v3 g( q- A# v4 v6 e, P Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections% P1 f4 V8 x' j- C
Press Release |
| 16. | Jublia) X6 Y- u% g' ]2 K" R. R1 G3 R2 w
7 i4 V7 d: o+ C7 l5 t | efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection)( Q, Z, K$ H1 a# i) z; d5 M0 I
No Press Release |
| 15. | Dalvance+ p2 Z# i/ n) L9 e* e/ m; c7 F: ?" u. K
) I' f5 L* A: K( ]* H2 b& R
| dalbavancin | 5/23/2014 | To treat adults with skin infections
) M: R1 ?/ G6 } Y; _. b# X Press Release |
| 14. | Entyvio
3 l/ r8 v+ H& K) F' O 3 A* w. g1 v1 l/ G! u I% [0 L- A
| vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease( K! y1 `$ J4 m; C& b& s2 V
Press Release |
| 13. | Zontivity
% P7 ^% s* P7 }% t
3 X* Q. d' B/ I' b | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients' ^2 p# P1 ?& {- S. @. z
Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)
& w% c6 |( z3 e" x$ w. k8 G) P7 L Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)
3 w9 v2 m0 X: M$ O, o Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma7 l, g- W. b* H$ c
Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes! \4 P3 Y9 _: g9 Y' B2 u7 T
Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)
9 z8 n8 c' p: M5 l: _( L Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis
/ E8 v4 E8 D. }9 V& \ Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency
! ]: m0 b3 U$ \ Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)
6 C( z& B! V( q9 F( G. ~ Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)! O9 g* o3 s7 x* ]) Q$ L
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes' Y6 Q) ~( Q9 [3 G0 H6 f/ H
Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对